National Center for Complementary and Integrative Health (NCCIH) Clinical Trials
Sponsors / National Center for Complementary and Integrative Health (NCCIH)
567 ClinicalTrials.gov entries name National Center for Complementary and Integrative Health (NCCIH) as the lead sponsor. The portfolio currently includes 46 recruiting studies, 11 active non-recruiting studies, and 472 completed studies. 16 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Cumulative planned enrollment across all listed trials is 111,074 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
Termination reasons: Other50% · Recruitment31% · Funding6% · Regulatory6% · Safety6%
Recent Terminations
- Pain"Due to Covid constraints on recruitment"
- Generalized Anxiety Disorder"Unable to fully enroll study."
- Cognitive Impairment"Participant study visits not possible during COVID-19 pandemic. Funder not able to support a continuation at some future date."
- Chronic, Non-neuropathic Back Pain"Synthesis of the chemical precursor for the neuroimaging radiotracer could not be produced in a stable fashion."
- Rheumatoid Arthritis"insufficient enrollment"
- Asthma"Inadequate recruitment"
- Obesity"Some capsules used in this study were been found to be cracked and leaking."
- NCT00983502 Stopped Oct 2010Chronic Fatigue Syndrome"IRB ended and NIH study ended"
- Diabetic Kidney Disease"unable to meet recruitment goal"
- NCT00200733 Stopped Mar 2004Depression
Active Trials (11 total)
- NCT02707029
- NCT03952624
- NCT06052631
- NCT05987592
- NCT06633926
- NCT03258580
- NCT07036705
- NCT07342530
- NCT02821741
- NCT05267340
- Myofascial Pain EARLY_PHASE1NCT05876858
- NCT02446262
- Mild Depression PHASE3NCT07464886
- NCT05527210
- NCT04712981
- NCT06778070
- Fibromyalgia NANCT04606095
- Chronic Pain NANCT05699252
- Chronic Pain NANCT06219408
- Resilience NANCT06919952